Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
This guide compares risk levels between bonds and stocks in retirement, outlining factors like market cycles, duration, and income needs.
28,627 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Policy shifts around AI chips could change how Nvidia and AMD ship GPUs worldwide. This article breaks down the risks...
The crypto market has cooled from its peaks, but two names consistently draw attention: Ethereum and Solana. This gui...
Two popular dividend payers, AGNC and Realty Income, appeal to income investors for different reasons. This guide bre...
Bitcoin has traded in volatile swings, prompting the question will bitcoin fall below $50,000. This guide breaks down...
A new set of futures is coming to the CME Group, tying Tesla and SpaceX to a cash-settled futures contract. This arti...
Applied Optoelectronics and Lumentum jumped about 15% on Monday as a major hyperscale contract and index-driven buyin...
Billionaire investor Peter Thiel arrives in Rome for a private four-day series on the Antichrist, drawing sharp quest...
Investors often wonder if AMD stock now is the right move. This guide analyzes the catalysts, risks, and practical st...
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Regulators are steering crypto away from its Wild West image. This shift could unlock real advantages for XRP, from c...
QuantumScape has fallen hard in early 2026. This guide walks you through what would move the stock higher, what could...